Industrial Farmaceutica Cantabria, Spain   Report issue

For profit Phase 3 Phase 4
Founded: Cantabria Spain (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2010
NCT01092884
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Industrial Farmacéutica Cantabria, S.A. | Nutricion Medica S.L.

Active Ingredients

Drugs in Phase 4 Trials (1)

passion flower (1 trial)

Drugs in Phase 3 Trials (1)

minoxidil (loniten) (2 trials)

Drugs in Other Trials (1)

polypodium leucotomos extract (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 3